Tenetech Inc. acquires approval from TFDA to enter Taiwan

Tenetech Inc has announced that it acquired approval from TFDA(Taiwanese Food and Drug Administration) to enter Taiwan.

According to Tentech Inc., 10THERMA was initially launched in South Korea in October of last year. Within its first year, 10THERMA has already surpassed 500 units . 10THERMA, a 400W monopolar RF device with a 5㎠ tip size, boasts a treatment area 25% larger than other monopolar devices. Additionally, 10THERMA can deliver 20% more heat energy.
One representative for Tentech Inc. said “Nowadays, People are much more interested in improving their skin than ever before. In the non-surgical skin tightening market industry, our product, 10THERMA, is rapidly gaining market share worldwide.”
By acquiring approval from TFDA, Tentech Inc. has started to expand it influence in the global market. From Oct 8th to Oct 10th, Tentech Inc is going to participate in ‘The 49th Annual Meeting of Taiwanese Dermatological Association’, held at Kaohsiung Exhibition Center in Taiwan. This event is the first showcase for 10THERMA in Taiwan. Prof. Park (Eunsoo), of Soonchunhyang University, is going to deliver a lecture about 10THERMA, titled ‘Monopolar RF Skin Tightening using innovative 10THERMA system.’
He added “To enter Taiwan, we prepared well. We have already found and signed Taiwan export contract with one of leading distributerS in Taiwan.” And mentioned “We expect to sell at least 100 units in the Taiwanese market by the end of this year.”
On the other hand, Tentech Inc. is planning to expand its presence in other key countries such as the U.S. and Brazil for 10THERMA.

Tenetech Inc. acquires approval from TFDA to enter Taiwan
Exit mobile version